Bank of New York Mellon Corp Has $9.07 Million Position in U.S. Physical Therapy, Inc. (NYSE:USPH)

Bank of New York Mellon Corp trimmed its holdings in shares of U.S. Physical Therapy, Inc. (NYSE:USPH - Free Report) by 5.2% in the first quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 125,366 shares of the company's stock after selling 6,920 shares during the period. Bank of New York Mellon Corp owned about 0.83% of U.S. Physical Therapy worth $9,071,000 as of its most recent SEC filing.

A number of other large investors have also recently added to or reduced their stakes in USPH. Point72 Asset Management L.P. acquired a new position in U.S. Physical Therapy in the 4th quarter worth approximately $18,886,000. Raymond James Financial Inc. acquired a new position in U.S. Physical Therapy in the 4th quarter worth approximately $6,240,000. Nuveen Asset Management LLC lifted its position in U.S. Physical Therapy by 95.9% in the 4th quarter. Nuveen Asset Management LLC now owns 120,893 shares of the company's stock worth $10,724,000 after buying an additional 59,190 shares in the last quarter. Envestnet Asset Management Inc. lifted its position in U.S. Physical Therapy by 20.1% in the 4th quarter. Envestnet Asset Management Inc. now owns 299,791 shares of the company's stock worth $26,594,000 after buying an additional 50,163 shares in the last quarter. Finally, Silvercrest Asset Management Group LLC lifted its position in U.S. Physical Therapy by 24.8% in the 4th quarter. Silvercrest Asset Management Group LLC now owns 189,115 shares of the company's stock worth $16,776,000 after buying an additional 37,523 shares in the last quarter.

Insider Buying and Selling at U.S. Physical Therapy

In other U.S. Physical Therapy news, Director Nancy Ham sold 400 shares of the business's stock in a transaction dated Thursday, June 12th. The shares were sold at an average price of $78.01, for a total value of $31,204.00. Following the transaction, the director directly owned 2,594 shares in the company, valued at $202,357.94. The trade was a 13.36% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Company insiders own 2.00% of the company's stock.

Analyst Upgrades and Downgrades

USPH has been the subject of a number of research analyst reports. Wall Street Zen upgraded shares of U.S. Physical Therapy from a "sell" rating to a "hold" rating in a research report on Thursday, May 8th. JMP Securities restated a "market outperform" rating and set a $113.00 price target on shares of U.S. Physical Therapy in a report on Tuesday, April 22nd. Finally, Barrington Research restated an "outperform" rating and set a $98.00 price target on shares of U.S. Physical Therapy in a report on Tuesday, July 1st. Two analysts have rated the stock with a hold rating, four have issued a buy rating and one has assigned a strong buy rating to the company's stock. According to data from MarketBeat.com, U.S. Physical Therapy currently has a consensus rating of "Moderate Buy" and an average price target of $109.00.

U.S. Physical Therapy Stock Performance

USPH remained flat at $74.33 during trading on Friday. 102,649 shares of the company traded hands, compared to its average volume of 195,715. The stock has a market capitalization of $1.13 billion, a price-to-earnings ratio of 34.10, a PEG ratio of 3.61 and a beta of 1.44. U.S. Physical Therapy, Inc. has a 12-month low of $62.77 and a 12-month high of $101.19. The company has a current ratio of 1.17, a quick ratio of 1.17 and a debt-to-equity ratio of 0.32. The company has a 50 day simple moving average of $76.52 and a 200 day simple moving average of $78.06.

U.S. Physical Therapy (NYSE:USPH - Get Free Report) last posted its quarterly earnings results on Wednesday, May 7th. The company reported $0.48 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.46 by $0.02. The company had revenue of $183.79 million for the quarter, compared to analyst estimates of $176.78 million. U.S. Physical Therapy had a net margin of 4.57% and a return on equity of 7.89%. The business's quarterly revenue was up 18.0% on a year-over-year basis. During the same period last year, the business posted $0.51 EPS. As a group, sell-side analysts anticipate that U.S. Physical Therapy, Inc. will post 2.67 earnings per share for the current fiscal year.

U.S. Physical Therapy Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Friday, June 13th. Stockholders of record on Friday, May 23rd were given a dividend of $0.45 per share. The ex-dividend date of this dividend was Friday, May 23rd. This represents a $1.80 annualized dividend and a dividend yield of 2.42%. U.S. Physical Therapy's dividend payout ratio (DPR) is currently 82.57%.

U.S. Physical Therapy Company Profile

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.